Nicotinic cholinergic antagonists: A novel approach for the treatment of autism
- 9 January 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 66 (5) , 985-990
- https://doi.org/10.1016/j.mehy.2005.11.015
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Neuronal Nicotinic Acetylcholine Receptors: Structural Revelations, Target Identifications, and Therapeutic InspirationsJournal of Medicinal Chemistry, 2005
- Attention, monotropism and the diagnostic criteria for autismAutism, 2005
- Neuroanatomic observations of the brain in autism: a review and future directionsInternational Journal of Developmental Neuroscience, 2005
- Developmental deficits in social perception in autism: the role of the amygdala and fusiform face areaInternational Journal of Developmental Neuroscience, 2005
- Neuronal nicotinic receptors: from structure to pathologyProgress in Neurobiology, 2004
- Nicotinic Acetylcholine Receptors as Drug TargetsCurrent Drug Targets-CNS & Neurological Disorders, 2004
- Autism as a disorder of neural information processing: directions for research and targets for therapyMolecular Psychiatry, 2004
- Nicotinic Treatment for Cognitive DysfunctionCurrent Drug Targets-CNS & Neurological Disorders, 2002
- Psychopharmacology in AutismPsychosomatic Medicine, 1999
- Presynaptic nicotinic ACh receptorsPublished by Elsevier ,1997